Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD34C antisense RNA 1 (ANKRD34C-AS1) is a long intergenic non-coding RNA (lincRNA/lncRNA) located on chromosome 15 on the reverse strand. As an antisense transcript, it does not code for protein but may regulate gene expression by modulating the expression of its sense gene partner or other genes in cis or trans. Evidence suggests ANKRD34C-AS1 is significantly downregulated in glioblastoma multiforme (GBM) and may be involved in cancer biology as a regulatory RNA, but its biological function and clinical significance remain poorly understood and require further study. There are no known drug interactions, disease biomarkers, or established roles as a therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANKRD34C antisense RNA 1 (ANKRD34C-AS1).